for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

PPD Inc

PPD.O

Latest Trade

19.85USD

Change

0.00(-0.00%)

Volume

1,763,091

Today's Range

19.17

 - 

20.66

52 Week Range

10.61

 - 

33.23

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
19.85
Open
19.50
Volume
1,763,091
3M AVG Volume
--
Today's High
20.66
Today's Low
19.17
52 Week High
33.23
52 Week Low
10.61
Shares Out (MIL)
348.58
Market Cap (MIL)
6,919.32
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

PPD Reports Q4 Earnings Per Share $0.02

PPD Sees FY 2019 Total Revenues In Range Of $4,020 Mln to $4,034 Mln

PPD Enters Into Second Amended And Restated Stockholders Agreement - SEC Filing

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About PPD Inc

PPD, Inc. provides drug development services to the biopharmaceutical industry. The Company provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The Company’s business segments include Clinical Development Services segment and Laboratory Services segment. Its Clinical Development Services offerings span the lifecycle of clinical product development and includes product development and consulting services, early development services, phases II-IV clinical trial management, accelerated enrollment solutions, peri- and post-approval services and medical communications. The Company’s Laboratory Services segment offers bioanalytical laboratory services, biomarker laboratory services, vaccine science services, good manufacturing practice (GMP) laboratory services and central laboratory services.

Contact Info

929 North Front Street

WILMINGTON, NC

28401-3331

United States

+1.910.2510081

Key Stats

1.64 mean rating - 14 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019

4.0K

2020(E)

4.2K
EPS (USD)

2019

1.020

2020(E)

1.094
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Shanghai tops world's IPO league table despite coronavirus

Shanghai has topped global initial public offering (IPO) league table for the first time in nearly three years, even as the coronavirus epidemic which originated in China rocked markets around the world.

BRIEF-PPD Reports Q4 Earnings Per Share $0.02

* SEES 2020 ADJUSTED EBITDA IN RANGE OF $855 MILLION TO $870 MILLION Source text for Eikon: Further company coverage:

CORRECTED-Debt sales make a comeback after coronavirus shutdown

Companies took advantage of a window of opportunity on Tuesday to launch debt sales on both sides of the Atlantic, after coronavirus concerns chilled deal markets last week.

Debt sales make a comeback after coronavirus shut-down

Companies took advantage of a window of opportunity on Tuesday to launch debt sales on both sides of the Atlantic, after coronavirus concerns chilled deal markets last week.

BRIEF-PPD Sees FY 2019 Total Revenues In Range Of $4,020 Mln to $4,034 Mln

* PPD INC SEES FY 2019 TOTAL REVENUES IN RANGE OF $4,020 MILLION - $4,034 MILLION

BRIEF-PPD Enters Into Second Amended And Restated Stockholders Agreement - SEC Filing

* PPD INC SAYS ON FEB10, COMPANY ENTERED INTO A SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT - SEC FILING

IFR US ECM Weekly Wrap-up

WEEKLY TOTAL $11.2bn – IPO $3.1bn – ABB/BLOCK $1.2bn – FOLLOW-ON $6.1bn – CB $825m Monday

Warner Music group files for initial public offering

Warner Music Group filed for an initial public offering on Thursday, making it the latest high-profile company opting for a public listing in 2020.

Drug research firm PPD's shares soar in U.S. market debut

Shares of drug research firm PPD Inc <PPD.O> rose 14.8% in their Nasdaq debut on Thursday, marking a stellar stock market entry for the second $1 billion-plus flotation of the year.

Shares of drug research firm PPD jump 15% in U.S. market debut

Shares of drug research firm PPD Inc rose 14.8% in their U.S. market listing, marking a stellar debut for the second $1 billion-plus flotation of the year.

IFR US ECM Calendar

Beam Therapeutics (US, biotech) – $180m IPO. 10.6m shares (100% prim) at $17.00, versus $15-$17 marketing. JPM, JEFF, BARC. Upsized to 9.25m shares from 6.25m shares on 2/5.

IFR US ECM Calendar

Beam Therapeutics (US, biotech) – $180m IPO. 10.6m shares (100% prim) at $17.00, versus $15-$17 marketing. JPM, JEFF, BARC. Upsized to 9.25m shares from 6.25m shares on 2/5.

Mattress seller Casper's IPO slashes valuation by more than half

Casper Sleep Inc <CSPR.N> on Wednesday sold shares in its initial public offering (IPO) at the bottom end of a targeted range it had already lowered, slashing the online mattress retailer's valuation by more than half in less than a year.

Drug research firm PPD prices IPO at top end of target

Drug research firm PPD Inc <PPD.O> said on Wednesday it raised $1.62 billion in its initial public offering (IPO) after pricing shares at the top end of its targeted range.

Drug research firm PPD prices IPO at top end of target

Drug research firm PPD Inc on Wednesday priced its initial public offering (IPO) at $27 per share, according to a person familiar with the matter, at the high end of its target range.

IFR US ECM Calendar

Integra LifeSciences (US, surgical equipment) – $500m 5.5y cvt at 0.5%, up 30% versus talk of 0.375%-0.875%, up 27.5%-32.5%. BOFA, MS, STRH, CITI, GS.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up